Todd Asset Management LLC Has $484,000 Position in Koninklijke Philips (NYSE:PHG)

Todd Asset Management LLC lessened its holdings in shares of Koninklijke Philips (NYSE:PHG) by 5.9% in the 4th quarter, Holdings Channel.com reports. The firm owned 19,122 shares of the technology company’s stock after selling 1,194 shares during the quarter. Todd Asset Management LLC’s holdings in Koninklijke Philips were worth $484,000 as of its most recent filing with the SEC.

Other hedge funds have also recently added to or reduced their stakes in the company. Bank of Montreal Can increased its position in Koninklijke Philips by 2,883.5% in the 3rd quarter. Bank of Montreal Can now owns 982,199 shares of the technology company’s stock worth $32,157,000 after buying an additional 949,278 shares during the period. IHT Wealth Management LLC acquired a new stake in shares of Koninklijke Philips in the third quarter worth $19,593,000. JPMorgan Chase & Co. increased its position in Koninklijke Philips by 315.0% during the third quarter. JPMorgan Chase & Co. now owns 245,729 shares of the technology company’s stock worth $8,040,000 after acquiring an additional 186,520 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in Koninklijke Philips during the 3rd quarter valued at $4,622,000. Finally, Jane Street Group LLC boosted its holdings in Koninklijke Philips by 787.9% in the 3rd quarter. Jane Street Group LLC now owns 128,686 shares of the technology company’s stock valued at $4,211,000 after purchasing an additional 114,193 shares during the period. Institutional investors own 13.67% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the stock. UBS Group upgraded shares of Koninklijke Philips from a “neutral” rating to a “buy” rating in a report on Thursday, February 20th. BNP Paribas upgraded Koninklijke Philips from a “neutral” rating to an “outperform” rating in a research note on Tuesday. Jefferies Financial Group upgraded Koninklijke Philips from an “underperform” rating to a “hold” rating in a research report on Tuesday, October 29th. Finally, StockNews.com raised Koninklijke Philips from a “hold” rating to a “buy” rating in a report on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, Koninklijke Philips has an average rating of “Moderate Buy”.

Koninklijke Philips Trading Up 2.9 %

Shares of PHG stock opened at $26.74 on Wednesday. The firm has a fifty day moving average of $26.29 and a 200-day moving average of $28.10. The stock has a market cap of $25.13 billion, a price-to-earnings ratio of -31.83, a P/E/G ratio of 0.82 and a beta of 0.77. Koninklijke Philips has a 52-week low of $19.75 and a 52-week high of $32.91. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.74 and a current ratio of 1.23.

Koninklijke Philips (NYSE:PHG) last posted its quarterly earnings results on Wednesday, February 19th. The technology company reported $0.54 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.55 by ($0.01). The business had revenue of $5.38 billion during the quarter, compared to analyst estimates of $5.10 billion. Koninklijke Philips had a positive return on equity of 10.85% and a negative net margin of 3.88%. On average, equities research analysts forecast that Koninklijke Philips will post 1.63 earnings per share for the current fiscal year.

Koninklijke Philips Cuts Dividend

The business also recently announced an annual dividend, which will be paid on Friday, June 6th. Investors of record on Tuesday, May 13th will be given a dividend of $0.886 per share. The ex-dividend date is Tuesday, May 13th. This represents a dividend yield of 2.9%. Koninklijke Philips’s dividend payout ratio (DPR) is presently -108.33%.

Koninklijke Philips Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.